Pharma giant Jazz dismisses final patent claim involving cannabinoid epilepsy drug
Global pharma company Jazz Pharmaceuticals has ended patent claims related to its cannabinoid-based epilepsy drug, Epidiolex.
News February 11
Latest In: cannabis patent dispute
Cannabis vaporizer makers score ‘definitive’ victory in patent dispute
The U.S. International Trade Commission "ruled definitively" in favor of dozens of vaporizer companies that were accused of…
News April 25
Trade agency rules in favor of cannabis vaporizer companies in patent suit
The International Trade Commission ruled in an initial determination that dozens of North American cannabis vaporizer companies did…
News February 2
Sponsored
The Medical Card Has a New Argument
Federal rescheduling handed the medical tier a tax tool it never expected. Whether operators use it — and how fast — is what the next few years of market data…
June 2
Lawsuit: Generic drugmakers infringed on Epidiolex cannabis drug patents
Global pharma giant Jazz Pharmaceuticals filed a lawsuit alleging that a list of generic drug companies infringed on…
News January 9
Court tosses Canopy cannabis patent infringement lawsuit against GW Pharma
A Texas court has dismissed a lawsuit brought by Canadian cannabis producer Canopy Growth against GW Pharmaceuticals, although…
News March 2
Federal judge allows landmark marijuana patent suit to proceed
A Denver federal judge denied an early motion to toss out most aspects of a landmark cannabis patent…
News April 25Featured
1
Latest Sponsored
